-
Vaccines, Blood & Biologics
-
Genetic Systems rLAV EIA
Proper Name: Human Immunodeficiency Virus Type 1
Tradename: Genetic Systems rLAV EIA
Manufacturer: Bio-Rad Laboratories, License #1109
Date: June 29, 1998
Indication: New HIV-1 enzyme immunoassay (EIA) which contains a combination of HIV-1 viral lysate and HIV-1 recombinant antigen
June 29, 1998 Approval Letter
Summary Basis of Approval (PDF - 4 MB)
-
Return to
- Complete List of Donor Screening Assays for Infectious Agents and HIV Diagnostic Assays
Product/Manufacturer Lists - Testing HCT/P Donors for Relevant Communicable Disease Agents and Diseases
Tissue Safety & Availability - Infectious Disease Tests
Blood Products - HIV-1
Infectious Disease Screening Assays
-
Contact Us
Consumer Affairs Branch (CBER)
- (800) 835-4709
- (301) 827-1800
- ocod@fda.hhs.gov
Division of Communication and Consumer Affairs
Office of Communication, Outreach and Development
Food and Drug Administration
1401 Rockville Pike
Suite 200N/HFM-47
Rockville, MD 20852-1448
-
-
-